L’AMCLI dal 1970 si occupa della Microbiologia clinica promuovendo la ricerca scientifica e la formazione, fornendo un supporto valido e insostituibile alla diagnostica clinica delle patologie infettive, con la promozione di percorsi clinico-diagnostici e terapeutici volti a criteri di appropriatezza e standard clinico professionali. Tutto finalizzato al raggiungimento dell’obiettivo primario della “Clinical Governance”, che è quello di favorire lo sviluppo dell’eccellenza nell’assistenza sanitaria.
iscrizioniIscriviti compilando il modulo online per entrare a far parte dell’associazione e scoprire i vantaggi riservati ai soci AMCLI.
rivistaÈ la rivista ufficiale dell’ AMCLI, pubblica papers di ricerca applicata nei settori di: batteriologia, micologia, virologia, parassitologia…
pubblicazioniElenco delle ultime pubblicazioni sostenute da AMCLI: Testo Atlante, infezioni genitali, Micobatteriologia clinica…
leggi e decretiPer rimanere aggiornati sulle ultime leggi e decreti inerenti al mondo della Microbiologia Clinica.
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si’Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab575, https://doi.org/10.1093/ofid/ofab575
Trends in Clinical Severity of Hospitalized Patients With Coronavirus Disease 2019—Premier Hospital Dataset, April 2020–April 2021
Geoffrey P Whitfield, Aaron M Harris, Sameer S Kadri, Sara Warner, Sapna Bamrah Morris …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab599, https://doi.org/10.1093/ofid/ofab599
Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019
Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, Pinelopi Kazakou, Emmanouil Koullias …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab588, https://doi.org/10.1093/ofid/ofab588
Ten Years of Diphtheria Toxin Testing and Toxigenic Cutaneous Diphtheria Investigations in Alberta, Canada: A Highly Vaccinated Population
Natalie C Marshall, Maulik Baxi, Clayton MacDonald, Angela Jacobs, Christopher A Sikora …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab414, https://doi.org/10.1093/ofid/ofab414
Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Julie Gayle …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab498, https://doi.org/10.1093/ofid/ofab498
Delay in the Effect of Restricting Community Mobility on the Spread of COVID-19 During the First Wave in the United States
Shan He, Jooyoung Lee, Benjamin Langworthy, Junyi Xin, Peter James …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab586, https://doi.org/10.1093/ofid/ofab586
Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
Teny M John, Abhishek Deshpande, Kyle Brizendine, Pei-Chun Yu, Michael B Rothberg
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab597, https://doi.org/10.1093/ofid/ofab597
Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
Adam Greenfield, Kassandra Marsh, Justin Siegfried, Ioannis Zacharioudakis, Nabeela Ahmed …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab522, https://doi.org/10.1093/ofid/ofab522
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
Romain Samuel Roth, Stavroula Masouridi-Levrat, Yves Chalandon, Anne-Claire Mamez, Federica Giannotti …
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab596, https://doi.org/10.1093/ofid/ofab596